| Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. |
| Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. |
| Proc Natl Acad Sci USA. 2002; 99(1): 365-70. |
| PMID 11756660 |
| |
| Prognostic significance of dysadherin expression in advanced colorectal carcinoma. |
| Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S. |
| Br J Cancer. 2003; 88(5): 726-32. |
| PMID 12618882 |
| |
| Cell adhesion system and human cancer morphogenesis. |
| Hirohashi S, Kanai Y. |
| Cancer Sci. 2003; 94(7): 575-81. (Review) |
| PMID 12841864 |
| |
| Dysadherin: expression and clinical significance in thyroid carcinoma. |
| Sato H, Ino Y, Miura A, Abe Y, Sakai H, Ito K, Hirohashi S. |
| J Clin Endocrinol Metab. 2003; 88(9): 4407-12. |
| PMID 12970317 |
| |
| Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. |
| Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S. |
| J Clin Oncol. 2003; 21(4): 659-67. |
| PMID 12586803 |
| |
| Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. |
| Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S. |
| Glycobiology. 2003; 13(7): 521-7. |
| PMID 12672699 |
| |
| Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. |
| Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S. |
| Appl Immunohistochem Mol Morphol. 2004; 12(4): 323-8. |
| PMID 15536331 |
| |
| Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma. |
| Shimada Y, Hashimoto Y, Kan T, Kawamura J, Okumura T, Soma T, Kondo K, Teratani N, Watanabe G, Ino Y, Sakamoto M, Hirohashi S, Imamura M. |
| Oncology. 2004; 67(1): 73-80. |
| PMID 15459499 |
| |
| Clinical significance of dysadherin expression in gastric cancer patients. |
| Shimada Y, Yamasaki S, Hashimoto Y, Ito T, Kawamura J, Soma T, Ino Y, Nakanishi Y, Sakamoto M, Hirohashi S, Imamura M. |
| Clin Cancer Res. 2004; 10(8): 2818-23. |
| PMID 15102690 |
| |
| Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. |
| Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y, Hirohashi S. |
| Cancer Res. 2004; 64(19): 6989-95. |
| PMID 15466191 |
| |
| Prognostic significance of dysadherin expression in cervical squamous cell carcinoma. |
| Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z. |
| Pathol Oncol Res. 2004; 10(4): 212-8. |
| PMID 15619642 |
| |
| Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. |
| Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. |
| Cancer Sci. 2004; 95(7): 575-82. |
| PMID 15245593 |
| |
| Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. |
| Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S. |
| Cancer. 2005; 103(8): 1693-700. |
| PMID 15751018 |
| |
| Prognostic significance of dysadherin expression in patients with non-small cell lung cancer. |
| Tamura M, Ohta Y, Tsunezuka Y, Matsumoto I, Kawakami K, Oda M, Watanabe G. |
| J Thorac Cardiovasc Surg. 2005; 130(3): 740-5. |
| PMID 16153922 |
| |
| Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. |
| Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K. |
| Virchows Arch. 2006; 448(6): 763-7. |
| PMID 16570180 |
| |
| Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. |
| Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Iwasaki H, Sonobe H, Goto H, Kusakabe H, Takahira T, Kobayashi C, Kawaguchi K, Saito T, Yamamoto H, Tamiya S, Iwamoto Y, Tsuneyoshi M. |
| Mod Pathol. 2006; 19(6): 820-31. |
| PMID 16557275 |
| |
| Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. |
| Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, Charalabopoulos K. |
| Am J Surg Pathol. 2006; 30(2): 185-93. |
| PMID 16434892 |
| |
| Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. |
| Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM. |
| Cancer Res. 2006; 66(14): 7176-84. |
| PMID 16849564 |
| |
| Expression of dysadherin and E-cadherin in trophoblastic tissue in normal and abnormal pregnancies. |
| Batistatou A, Makrydimas G, Zagorianakou N, Zagorianakou P, Nakanishi Y, Agnantis NJ, Hirohashi S, Charalabopoulos K. |
| Placenta. 2007; 28(5-6): 590-2. |
| PMID 17084448 |
| |
| In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. |
| Batistatou A, Peschos D, Tsanou H, Charalabopoulos A, Nakanishi Y, Hirohashi S, Agnantis NJ, Charalabopoulos K. |
| Br J Cancer. 2007; 96(9): 1404-8. |
| PMID 17437014 |
| |
| Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. |
| Conway-Campbell BL, Wooh JW, Brooks AJ, Gordon D, Brown RJ, Lichanska AM, Chin HS, Barton CL, Boyle GM, Parsons PG, Jans DA, Waters MJ. |
| Proc Natl Acad Sci U S A. 2007; 104(33): 13331-6. |
| PMID 17690250 |
| |
| Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. |
| Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M. |
| Am J Surg Pathol. 2007; 31(1): 85-94. |
| PMID 17197923 |
| |
| Dysadherin: a new player in cancer progression. |
| Nam JS, Hirohashi S, Wakefield LM. |
| Cancer Lett. 2007; 255(2): 161-9. (Review) |
| PMID 17442482 |
| |
